2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Abt Associates: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel Flublok™ Quadrivalent by Sanofi, Inc., VaxigripTetra™ by Sanofi, Inc. - Influenza | Phase 4 | Completed | Centers for Disease Control and Prevention | 577 | 2019-10-31 | 2023-11-15 |
| Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP Flublok, Flucelvax, Fluarix - Influenza | Phase 4 | Completed | Centers for Disease Control and Prevention | 944 | 2018-09-12 | 2024-07-22 |
Influenza, Human (2)
FluBlok (1) · Fluzone High-Dose (1) · Influenza Vaccines (1) · fluarix (1)
Israel (1) · United States (1)
Brendan Flannery, PhD (1) · Fatimah Dawood, MD (1) · Mark G Thompson, PhD (1)